Dichlorophen

CAS No. 97-23-4

Dichlorophen( Dichlorophen | NSC 38642 | NSC-38642 | NSC38642 )

Catalog No. M16878 CAS No. 97-23-4

Nontoxic laxative vermicide effective for taenia infestation. It tends to produce colic and nausea.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
500MG 37 In Stock
1G 43 In Stock

Biological Information

  • Product Name
    Dichlorophen
  • Note
    Research use only, not for human use.
  • Brief Description
    Nontoxic laxative vermicide effective for taenia infestation. It tends to produce colic and nausea.
  • Description
    Nontoxic laxative vermicide effective for taenia infestation. It tends to produce colic and nausea. It is also used as a veterinary fungicide, anthelmintic, and antiprotozoan.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Dichlorophen | NSC 38642 | NSC-38642 | NSC38642
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    Infection
  • Indication
    ——

Chemical Information

  • CAS Number
    97-23-4
  • Formula Weight
    269.13
  • Molecular Formula
    C13H10Cl2O2
  • Purity
    >98% (HPLC)
  • Solubility
    Water: 30 mg/L.
  • SMILES
    OC1=CC=C(Cl)C=C1CC2=CC(Cl)=CC=C2O
  • Chemical Name
    2,2'-Methylenebis(4-chlorophenol)

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Langrand J, et al. Clin Toxicol (Phila). 2013 Mar;51(3):178-8
molnova catalog
related products
  • Pteropodine

    Pteropodine acts as a positive modulator of muscarinic M(1) and 5-HT(2) receptors. Pteropodine shows antigenotoxic, antioxidant and lymphocyte induction effects, it also shows strong apoptotic effect on acute leukaemic lymphoblasts.

  • KPT-6566

    KPT-6566 is a novel selective covalent pin1 inhibitor KPT-6566 shows an IC50 of 640?nM and a Ki of 625.2 nM for PIN1 PPIase domainand has anti-cancer activity.

  • Ingenol

    Ingenol mebutate is an effective treatment for actinic keratosis. 2. Formulating novel derivatives from Ingenol esters may be an innovative approach to develop new lead compounds to reactivate latent HIV.